CTA Investigational Product Management 3

Question 1

What is the significance of lot numbers for investigational products in clinical trials?

Accepted Answer

They allow tracking of product batches for quality control, recalls, and accountability purposes

Answer

They indicate the price paid by the sponsor for that batch of drug

Answer

They identify the specific participant who is assigned to use that product

Answer

They represent the sequence in which participants were randomized

Question 2

How should investigational products be reconciled at the end of a clinical trial?

Accepted Answer

All dispensed, returned, and destroyed IP quantities are accounted for against total received to verify no unexplained discrepancies

Answer

The site disposes of all remaining IP independently and notifies the sponsor by email

Answer

Remaining IP is donated to local pharmacies for patient use

Answer

The final reconciliation is performed exclusively by the sponsor's auditor without site involvement

Question 3

What is a Certificate of Analysis (CoA) for investigational products and why is it important?

Accepted Answer

A document from the manufacturer certifying that a specific IP lot meets defined quality specifications

Answer

A financial document confirming the sponsor paid for the drug batch

Answer

An IRB certificate confirming the trial protocol was analyzed and approved

Answer

A site certificate confirming all staff are trained to handle the investigational product

Question 4

What information must be documented each time investigational product is dispensed to a trial participant?

Accepted Answer

Participant ID, date, kit or lot number, dose dispensed, quantity, and the name of the person who dispensed it

Answer

Participant's home address and insurance information

Answer

The participant's complete medical history and concomitant medications list

Answer

The IRB approval number and the study title only

Question 5

What is a 're-supply request' in the context of investigational product management?

Accepted Answer

A formal request from the site to the sponsor to ship additional IP when supplies are running low

Answer

A participant's request to receive a higher dose of study medication

Answer

A regulatory filing to expand the approved IP indication

Answer

An IRB amendment to approve use of additional drug quantities

Question 6

What is the role of the investigational site pharmacy in clinical trial IP management?

Accepted Answer

The pharmacy is responsible for IP receipt, storage, randomization, dispensing, and accountability documentation per protocol

Answer

The pharmacy negotiates drug pricing directly with the sponsor on behalf of participants

Answer

The pharmacy submits the IND application to the FDA on behalf of the sponsor

Answer

The pharmacy is only involved in ordering commercial medications for participant co-medications

Question 7

What does 'comparator product' mean in the context of investigational product management?

Accepted Answer

An approved drug or placebo used alongside the investigational drug to compare efficacy and safety in the trial

Answer

A product used by the sponsor to compare manufacturing costs between suppliers

Answer

A laboratory reagent used to compare biological samples from different participant groups

Answer

A competing sponsor's drug that is benchmarked during regulatory review